Company intelligence / Profile preview

ViiV Healthcare

London, England, United Kingdomviivhealthcare.com ↗

Ownership: Private
Employees: ~1300
Development stage: Commercial

Overview

ViiV Healthcare has a broad portfolio of approved antiretroviral therapies for the treatment and prevention of HIV. Its products include some of the most widely used modern regimens for both daily oral and long-acting injectable administration. The company’s clinical results have demonstrated high efficacy in viral suppression and PrEP (pre-exposure prophylaxis) with favorable safety profiles.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeBiologic
Industry: Pharma

Drug pipeline

20 assets

dolutegravir

Approved

19 more assets in the full pipeline.

Partnerships

Bristol Myers Squibb R&D asset acquisitionvoluntary licensing partnerships with generic manufacturers for access programscollaborations with academic institutions such as University of South Carolina's Ryan White Program

Beyond the preview

Go deeper on ViiV Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViiV Healthcare.